Pluripotent stem cells as new drugs? The example of Parkinson's disease

International Journal of Pharmaceutics

Volumn 381, Issue 2, 2009, Pages 113-121

  Preynat Seauve, Olivier ^a,b   Burkhard, Pierre R ^a   Villard, Jean ^a   Zingg, Walter ^a   Ginovart, Nathalie ^b   Feki, Anis ^a   Dubois Dauphin, Michel ^b   Hurst, Samia A ^b   Mauron, Alex ^b   Jaconi, Marisa ^b   Krause, Karl Heinz ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cell replacement therapy; Dopaminergic neurons; Embryonic stem cells; Parkinson's disease; Regenerative medicine

Indexed keywords

6 FLUORODOPA F 18; LEVODOPA;

ARTICLE; BACTERIUM CONTAMINATION; BRAIN FUNCTION; CELL DIFFERENTIATION; CLINICAL PROTOCOL; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; DYSKINESIA; EMBRYONIC STEM CELL; GOOD MANUFACTURING PRACTICE; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; INFECTION; MEDICAL ETHICS; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA; TARGET CELL;

ANIMALS; CELL DIFFERENTIATION; HUMANS; PARKINSON DISEASE; PLURIPOTENT STEM CELLS;

EID: 70349278463     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.03.003     Document Type: Article

References (73)

1. Abbott A. Swiss court bans work on macaque brains. Nature 453 (2008) 833
2. Akalin E., et al. Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. Am. J. Transplant. 3 (2003) 731-735
3. Astradsson A., et al. Recent advances in cell-based therapy for Parkinson disease. Neurosurg. Focus 24 (2008) E6
4. Atkinson K., et al. The development of the acquired immunodeficiency syndrome after bone-marrow transplantation. Med. J. Aust. 147 (1987) 510-512
5. Baker D.E., et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25 (2007) 207-215
6. Barberi T., et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotechnol. 21 (2003) 1200-1207
7. Ben-Hur T., et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 22 (2004) 1246-1255
8. Blum B., and Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv. Cancer Res. 100 (2008) 133-158
9. Brooks D.J. Positron emission tomography imaging of transplant function. NeuroRx 1 (2004) 482-491
10. Brundin P., et al. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 9 (2000) 179-195
11. Chan S., and Harris J. Adam's fibroblast? The (pluri)potential of iPCs. J. Med. Ethics 34 (2008) 64-66
12. Christophersen N.S., and Brundin P. Large stem cell grafts could lead to erroneous interpretations of behavioral results?. Nat. Med. 13 (2007) 118-119 (118; author reply)
13. Cobo F., et al. Microbiological contamination in stem cell cultures. Cell Biol. Int. 31 (2007) 991-995
14. Cobo F., et al. Electron microscopy reveals the presence of viruses in mouse embryonic fibroblasts but neither in human embryonic fibroblasts nor in human mesenchymal cells used for hESC maintenance: toward an implementation of microbiological quality assurance program in stem cell banks. Cloning Stem Cells 10 (2008) 65-74
15. Cochen V., et al. Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. Mov. Disord. 18 (2003) 928-932
16. Deierborg T., et al. Emerging restorative treatments for Parkinson's disease. Prog. Neurobiol. 85 (2008) 407-432
17. Draper J.S., et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 22 (2004) 53-54
18. Drukker M., et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24 (2006) 221-229
19. Drukker M., et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 9864-9869
20. Dunnett S.B., et al. Cell therapy in Parkinson's disease - stop or go?. Nat. Rev. Neurosci. 2 (2001) 365-369
21. Englund U., et al. Transplantation of human neural progenitor cells into the neonatal rat brain: extensive migration and differentiation with long-distance axonal projections. Exp. Neurol. 173 (2002) 1-21
22. Freed C.R., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344 (2001) 710-719
23. Gerfen C.R., et al. Crossed connections of the substantia nigra in the rat. J. Comp. Neurol. 207 (1982) 283-303
24. Goetz C.G., et al. United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up. Neurology 41 (1991) 1719-1722
25. Gonzalez-Perez M.P., et al. Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor. Transplantation 75 (2003) 1006-1011
26. Grinnemo K.H., et al. Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod. Biomed. Online 13 (2006) 712-724
27. Hagell P., et al. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122 Pt 6 (1999) 1121-1132
28. Hall V.J., et al. Restorative cell therapy for Parkinson's disease: a quest for the perfect cell. Semin. Cell Dev. Biol. 18 (2007) 859-869
29. Hauser R.A., et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 56 (1999) 179-187
30. Herszfeld D., et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat. Biotechnol. 24 (2006) 351-357
31. Joannides A.J., et al. A scaleable and defined system for generating neural stem cells from human embryonic stem cells. Stem Cells 25 (2007) 731-737
32. Kawasaki H., et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28 (2000) 31-40
33. Kelly C.M., et al. Striatal graft projections are influenced by donor cell type and not the immunogenic background. Brain 130 (2007) 1317-1329
34. Kim J.H., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 (2002) 50-56
35. Koivisto H., et al. Cultures of human embryonic stem cells: serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor. Reprod. Biomed. Online 9 (2004) 330-337
36. Lei T., et al. Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges. Cell Res. 17 (2007) 682-688
37. Li J.Y., et al. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci. 31 (2008) 146-153
38. Lindvall O., et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247 (1990) 574-577
39. Lindvall O., and Bjorklund A. Cell therapy in Parkinson's disease. NeuroRx 1 (2004) 382-393
40. Madrazo I., et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med. 316 (1987) 831-834
41. Mallon B.S., et al. Toward xeno-free culture of human embryonic stem cells. Int. J. Biochem. Cell Biol. 38 (2006) 1063-1075
42. Martin M.J., et al. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11 (2005) 228-232
43. Mendez I., et al. Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease. Brain Res. Brain Res. Rev. 32 (2000) 328-339
44. Mendez I., et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J. Neurosurg. 96 (2002) 589-596
45. Mendez I., et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128 (2005) 1498-1510
46. Morizane A., et al. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease. Cell Tissue Res. 331 (2008) 323-336
47. Nat R., et al. Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures. Glia 55 (2007) 385-399
48. Nguyen J., et al. [Acute extrapyramidal manifestations caused by domperidone]. Arch. Pediatr. 7 (2000) 1131-1132
49. Nishikawa S., et al. The promise of human induced pluripotent stem cells for research and therapy. Nat. Rev. Mol. Cell Biol. 9 (2008) 725-729
50. Odeberg J., et al. Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression. J. Neuroimmunol. 161 (2005) 1-11
51. Olanow C.W., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54 (2003) 403-414
52. Perrier A.L., et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 12543-12548
53. Rodriguez-Gomez J.A., et al. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25 (2007) 918-928
54. Roy N.S., et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12 (2006) 1259-1268
55. Russmann H., et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology 63 (2004) 1952-1954
56. Schulz T.C., et al. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 22 (2004) 1218-1238
57. Simonds R.J., et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N. Engl. J. Med. 326 (1992) 726-732
58. Simpson E., et al. Minor H antigens: genes and peptides. Eur. J. Immunogenet. 28 (2001) 505-513
59. Singh N.N., et al. Soles of the Feet: a mindfulness-based self-control intervention for aggression by an individual with mild mental retardation and mental illness. Res. Dev. Disabil. 24 (2003) 158-169
60. Soyama A., et al. Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation. Liver Transpl. 14 (2008) 647-650
61. Sugarman J. Human stem cell ethics: beyond the embryo. Cell Stem Cell 2 (2008) 529-533
62. Takagi Y., et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest. 115 (2005) 102-109
63. Tweedell K.S. New paths to pluripotent stem cells. Curr. Stem. Cell Res. Ther. 3 (2008) 151-162
64. Unger C., et al. Derivation of human skin fibroblast lines for feeder cells of human embryonic stem cells. Curr. Protocols Stem Cell Biol. (2008) 7 (Chapter 1, Unit 1C)
65. Unger C., et al. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet. 17 (2008) R48-53
66. Uphoff C.C., and Drexler H.G. Detection of mycoplasma contaminations. Methods Mol. Biol. 290 (2005) 13-23
67. Wernig M., et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 5856-5861
68. Wictorin K., et al. Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature 347 (1990) 556-558
69. Wictorin K., et al. Extensive efferent projections of intra-striatally transplanted striatal neurons as revealed by a species-specific neurofilament marker and anterograde axonal tracing. Prog. Brain Res. 82 (1990) 391-399
70. Wictorin K., et al. Efferent Projections to the Host Brain from Intrastriatal Striatal Mouse-to-rat Grafts: Time Course and Tissue-type Specificity as Revealed by a Mouse Specific Neuronal Marker. Eur. J. Neurosci. 3 (1991) 86-101
71. Winkler C., et al. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci. 28 (2005) 86-92
72. Yamanaka S. Pluripotency and nuclear reprogramming. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 363 (2008) 2079-2087
73. Yan Y., et al. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23 (2005) 781-790